Skye Global Management LP Bridge Bio Pharma, Inc. Transaction History
Skye Global Management LP
- $4.03 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
285Shares Held
170MCall Options Held
7.41MPut Options Held
2.61M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$774 Million40.56% of portfolio
-
Viking Global Investors LP25.1MShares$626 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$261 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$151 Million64.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.69B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...